US Patent 7211411 Human papilloma virus treatment
Patent 7211411 was granted and assigned to Nventa Biopharmaceuticals Corporation on May, 2007 by the United States Patent and Trademark Office.
All edits
Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
US Patent 07211411 Human papilloma virus treatment US Patent 7211411 Human papilloma virus treatment
US Patent 07211411 Human papilloma virus treatment
Find more entities like US Patent 7211411 Human papilloma virus treatment
